COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 6 of 7 for:    sunitinib | Recruiting, Not yet recruiting Studies | Neuroendocrine Tumors

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (FIRSTMAPPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01371201
Recruitment Status : Recruiting
First Posted : June 10, 2011
Last Update Posted : January 26, 2017
National Cancer Institute, France
ENSAT-CANCER European Network for the Study of Adrenal Tumours
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris